AZITHROMYCIN UPTAKE AND INTRACELLULAR ACCUMULATION BY TOXOPLASMA GONDII-INFECTED MACROPHAGES

被引:12
作者
BLAIS, J
BEAUCHAMP, D
CHAMBERLAND, S
机构
[1] CHU LAVAL,CTR RECH,SERV INFECTIOL LAB,LAVAL,PQ,CANADA
[2] UNIV LAVAL,FAC MED,DEPT MICROBIOL,LAVAL,PQ,CANADA
基金
英国医学研究理事会;
关键词
D O I
10.1093/jac/34.3.371
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The uptake of azithromycin and erythromycin was measured in RAW 264.7 mouse macrophages infected with Toxoplasma gondii to determine whether the activity of macrolides could be correlated with their degree of host cell penetration. Uptake was expressed as the ratio of the intracellular (I) to the extracellular (E) concentrations. After infection, the intracellular accumulation of macrolides was equivalent to that measured in uninfected cells and azithromycin reached an I/E ratio of 105.8 ± 80 in infected macrophages incubated with 20 mg/L of drug. The release of azithromycin from macrophages previously exposed to the drug was enhanced by exposure to Micrococcus luteus and phorbol myristate acetate but not after infection with T. gondii. Azithromycin accumulates readily and remains inside T. gondii-infected macrophages thereby interfering with the growth of the parasite which was confirmed by growth-inhibition experiments and by electron microscopy. © 1994 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:371 / 382
页数:12
相关论文
共 44 条
[1]   INHIBITION OF TOXOPLASMA-GONDII PROTEIN-SYNTHESIS BY AZITHROMYCIN [J].
BLAIS, J ;
GARNEAU, V ;
CHAMBERLAND, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1701-1703
[2]   INVITRO AND INVIVO INTRALEUKOCYTIC ACCUMULATION OF AZITHROMYCIN (CP-62, 993) AND ITS INFLUENCE ON EXVIVO LEUKOCYTE CHEMILUMINESCENCE [J].
BONNET, M ;
VANDERAUWERA, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1302-1309
[3]   SYNTHESIS, INVITRO AND INVIVO ACTIVITY OF NOVEL 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A DERIVATIVES - A NEW CLASS OF MACROLIDE ANTIBIOTICS, THE AZALIDES [J].
BRIGHT, GM ;
NAGEL, AA ;
BORDNER, J ;
DESAI, KA ;
DIBRINO, JN ;
NOWAKOWSKA, J ;
VINCENT, L ;
WATROUS, RM ;
SCIAVOLINO, FC ;
ENGLISH, AR ;
RETSEMA, JA ;
ANDERSON, MR ;
BRENNAN, LA ;
BOROVOY, RJ ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
GIRARD, AE ;
GIRARD, D ;
HERBERT, C ;
MANOUSOS, M ;
MASON, R .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1029-1047
[4]   IN-VITRO EVALUATION OF THE ACTIVITIES OF AZITHROMYCIN ALONE AND COMBINED WITH PYRIMETHAMINE AGAINST TOXOPLASMA-GONDII [J].
CANTIN, L ;
CHAMBERLAND, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1993-1996
[5]   CELLULAR UPTAKE AND SUBCELLULAR-DISTRIBUTION OF ROXITHROMYCIN AND ERYTHROMYCIN IN PHAGOCYTIC-CELLS [J].
CARLIER, MB ;
ZENEBERGH, A ;
TULKENS, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 :47-56
[6]  
CHAMBERLAND S, 1991, P SOC EXP BIOL MED, V197, P150
[7]   COMPARATIVE ACTIVITY OF MACROLIDES AGAINST TOXOPLASMA-GONDII DEMONSTRATING UTILITY OF AN INVITRO MICROASSAY [J].
CHAMBERLAND, S ;
KIRST, HA ;
CURRENT, WL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :903-909
[8]   INVITRO EFFECTS OF 4 MACROLIDES (ROXITHROMYCIN, SPIRAMYCIN, AZITHROMYCIN [CP-62,993], AND A-56268) ON TOXOPLASMA-GONDII [J].
CHANG, HR ;
PECHERE, JCF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) :524-529
[9]  
CUFFINI AM, 1989, MICROBIOS, V57, P167
[10]  
DEROUIN F, 1988, PATHOL BIOL, V36, P1204